Botulinum toxin in the treatment of tardive dystonia [8]

Journal of Clinical Psychopharmacology

Volumn 17, Issue 6, 1997, Pages 497-498

  Chatterjee, A ^a   Gordon, M F ^a   Giladi, N ^a   Trosch, R ^a  

^a ZUCKER HILLSIDE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACLOFEN; BENZATROPINE; BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLONAZEPAM; CLOZAPINE; MUSCLE RELAXANT AGENT; NEUROLEPTIC AGENT; RESERPINE; TETRABENAZINE;

ADULT; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; DYSPHAGIA; DYSTONIA; FLU LIKE SYNDROME; HUMAN; LETTER; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PTOSIS; TARDIVE DYSKINESIA;

ADULT; BOTULINUM TOXIN TYPE A; DOPAMINE ANTAGONISTS; DYSKINESIA, DRUG-INDUCED; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROMUSCULAR AGENTS; RETROSPECTIVE STUDIES;

EID: 0031396610     PISSN: 02710749     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004714-199712000-00016     Document Type: Letter

References (11)